Literature DB >> 9832284

Survey of anaerobic susceptibility patterns: a French multicentre study.

F Mory1, A Lozniewski, S Bland, A Sedallian, G Grollier, F Girard-Pipau, M F Paris, L Dubreuil.   

Abstract

In 1996, the in vitro antibiotic susceptibility of 463 anaerobes was measured in five hospitals using the reference agar dilution method. None of the 209 B. fragilis group strains showed resistance to imipenem or ticarcillin-clavulanic acid. High resistance rates (29%) were observed for cefotetan and clindamycin. beta-Lactamase production was detected respectively in 64% of the Prevotella and 7% of the Fusobacterium strains. Because the same standardized methods were used for many years, the authors were able to evaluate the evolution of antibiotic resistance. Clindamycin resistance had increased within the B. fragilis group (from 14% in 1992 to 29% in 1996) and also among strains of clostridia (32%), P. acnes (18%) and Peptostreptococcus (28%). In the B. fragilis group multidrug resistance was unlikely to occur.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832284     DOI: 10.1016/s0924-8579(98)00041-7

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port.

Authors:  Corinne Arpin; Véronique Dubois; Anne-Marie Rogues; Fanny Menard; Anne-Marie Gavinet; Jean-Pierre Maire; Jean-Pierre Gachie; Marie-Christine Bezian; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

2.  Isolation, Identification and Antimicrobial Susceptibility of Anaerobic Bacteria: A Study Re-emphasizing Its Role.

Authors:  Ritu Garg; Neelam Kaistha; Varsha Gupta; Jagdish Chander
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Plasmid-related resistance to cefoxitin in species of the Bacteroides fragilis group isolated from intestinal tracts of calves.

Authors:  F dos Santos Almeida; M J Avila-Campos
Journal:  Curr Microbiol       Date:  2006-10-03       Impact factor: 2.188

4.  In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.

Authors:  A Liebetrau; A C Rodloff; J Behra-Miellet; L Dubreuil
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

5.  Prevotella melaninogenica, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?

Authors:  Claudie Lamoureux; Charles-Antoine Guilloux; Elise Courteboeuf; Stéphanie Gouriou; Clémence Beauruelle; Geneviève Héry-Arnaud
Journal:  Microorganisms       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.